The Trump administration is awarding a $354 million four-year contract to a Virginia-based company to manufacture generic medicines and pharmaceutical ingredients needed to treat COVID-19, the company announced Tuesday. Phlow Corp. said in a release it was awarded the federal contract to create “essential medicines at risk of shortage,” including medicines for the COVID-19 pandemic response.”Years from now, historians will see this innovative…
More Stories
LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.
At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC
Two LA County sheriff’s deputies involved in the fatal shooting of Andres Guardado relieved of duties following unrelated investigation